NEW YORK (GenomeWeb News) – Cell Biosciences has sold one of its protein analysis systems to The University of Manchester, the company said today.

The university will use the system in its Stem Cell and Leukemia Proteomics Laboratory to study how phosphoprotein signaling processes in hematopoietic stem calls are different during leukemia.

The platform is a nanofluidic immunoassay system designed to analyze extremely small biological samples, and it can measure cell signaling proteins reproducibly in numbers as small as 25 cells.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.